In a Reuters article covering Figma's increased IPO valuation target of $18.8 billion, IPOX® Vice President Kat Liu provided commentary on the strong investor appetite for the offering. The article notes the high demand for technology stocks with solid fundamentals. Highlighting the key driver behind the interest, Liu stated, "Investors are responding to companies with credible AI exposure and Figma has done a good job aligning itself with the theme."

In an interview with finews.ch, IPOX® Founder and CEO Josef Schuster analyzed the dynamic transformation of capital markets in the Gulf Cooperation Council (GCC) region. He highlighted the growing importance of GCC listings in IPOX’s global strategies and weighed in on the potential IPO of Emirates airline, calling it a “landmark event for global aviation” and a “trophy asset.” The discussion also covered the active 2025 IPO climate and strong investor appetite in the region.

In a Reuters article covering the successful IPO of Accelerant, IPOX® Research Associate Lukas Muehlbauer provided expert commentary on the surge in insurance listings. He noted that recent market volatility has prompted a "flight to quality," with investors favoring the predictable cash flows and defensive models of insurance companies.

In its coverage of the McGraw Hill IPO, IFR quoted IPOX® VP Kat Liu She commented on the offering, which priced below its expected range, anticipating a "tepid debut" for the company. Liu also noted the firm has "long-term potential" as it works to build momentum.

In a recent article by Reuters, IPOX® Associate Lukas Muehlbauer offered his analysis on the market debut of firearms retailer GrabAGun (PEW). Muehlbauer comments on the company's decision to go public via a SPAC merger, noting, "The company's polarizing brand likely led it to choose a SPAC merger over a traditional IPO, exposing it to the market's skepticism."

In a Reuters article covering McGraw Hill's planned $4.2 billion IPO, IPOX® Vice President Kat Liu provided insight into the current market. She noted that the IPO window "feels more tactical than structural," prompting private equity sponsors to accelerate listing timelines "to get ahead of potential volatility" and secure liquidity while the opportunity is available.

IPOX® Research Associate Dr. Lukas Muehlbauer commented on key trends in European IPOs for Bloomberg, noting the best listings have been growth stories where proceeds are reinvested into the company, rather than deals where private equity owners cash out. Muehlbauer added that companies listing in the Nordic region and recent smaller listings have been the primary beneficiaries.

In a Bloomberg feature on private equity-backed companies returning to the public markets, IPOX® Founder Josef Schuster provided key insights. He explained that these offerings are "usually more efficiently priced than other IPOs, so we don’t expect to see a significant pop initially," despite a wide-open IPO window.

In a new report, Zacks Investment Research highlights two IPOX®-based ETFs (FPX, FPXI) as prime ways to access the recovering IPO market. Citing a sharp rebound in new listings and strong investor sentiment, the analysis points to significant growth opportunities. Our flagship U.S. and International indexes provide the basis for these featured funds.

In a Reuters article on Ambiq Micro's U.S. IPO filing, IPOX® Research Associate Lukas Muehlbauer provided analysis on the company’s plans. He noted the chip designer's customer concentration risk but also highlighted its competitive advantage in the wearables market by targeting the "AI at the edge" niche with its ultra-low-power chips.

In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the significant rights issuance planned by Saudi Arabia's ACWA Power Co. The utility company is set to undertake the Middle East's largest such deal since 2023, aiming to raise $1.9 billion to fund its strategic expansion.

In a Reuters article covering the strong market debut of Jefferson Capital, IPOX® Research Associate Lukas Muehlbauer provided commentary on the recovering U.S. IPO market. He noted the rebound is likely to be selective, "led by high-quality and long-anticipated issuers." Muehlbauer explained that an initial trading "pop" is part of the market's "healthy process of price discovery" to establish a sustainable price. Read more in the full article on the IPOX website.

In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the challenging European IPO market. Highlighting the recent withdrawal of several listings, Muehlbauer noted that investor appetite is particularly low for private equity exits where proceeds do not benefit the company. He stated, “Deals that are essentially existing owners cashing out are proving to be a tough sell.” Read more about his analysis of the current market sentiment on our blog.

The IPOX® 100 U.S. Index (ETF: FPX) is opening at a new all-time high, extending its year-to-date gain to +21%. This surge is driven by positive market sentiment, end-of-quarter positioning, and reassuring inflation comments from the FED. Other key indexes, including the IPOX® International (FPXI) and IPOX® 100 Europe (FPXE), also closed at multi-year highs, reflecting broad strength across the IPOX® portfolio and its position as the gold standard for IPOs.

IPOX® Research Associate Lukas Muehlbauer commented on the news of Wealthfront Corporation's confidential U.S. IPO filing in a Reuters article on June 23, 2025. He noted that the move is consistent with a recent positive trend in the market, stating, "Wealthfront's IPO plans fit in with the recent uptick of successful U.S. IPOs, particularly from sectors insulated from trade and supply chain volatility."

In a Reuters article on Slide Insurance's $2.6 billion IPO, IPOX® Vice President Kat Liu provided expert insights. Liu commented on the firm's niche strategy in high-risk coastal markets and the appeal of insurer IPOs due to predictable cash flows. She also offered perspective on potential governance concerns at the newly public company, highlighting IPOX's expertise in analyzing new listings and market trends in the global financial sector.

In a recent Bloomberg feature, IPOX® Founder and CEO Josef Schuster analyzed the potential IPO of Vale SA’s base metals unit. He noted a listing based on its $25 billion valuation could be the most valuable mining stock debut since Glencore Plc in 2011, stating it “would definitely rank amongst the top 10 mining IPOs.” This commentary underscores the historic scale of the potential offering in the global materials sector. Read more here.

IPOX® Research Associate Dr. Lukas Muehlbauer provided commentary for Bloomberg News on the volatile debut of Saudi Arabian low-cost carrier Flynas and the company's resilience in the face of increased regional instability.

IPOX® Research Associate Dr. Lukas Muehlbauer commented on the U.S. IPO filing of Australian meat producer Kilcoy Global Foods. The article discusses the recent resurgence in the U.S. IPO market and notes that Kilcoy's listing will be a significant indicator of investor appetite for companies with intricate global supply chains.

In a Reuters article covering Chime’s IPO, IPOX® VP Kat Liu, provided expert commentary on the implications of the company’s strong market reception. Ms. Liu noted that the performance of a high-profile "unicorn" like Chime is being closely watched and could encourage other private fintech companies to move forward with their own public offerings.